Search Results - richard+johnson

1 Results

Sort By:

AMPD2 Inhibitors for Treatment/Prevention of Obesity, Diabetes, Metabolic Syndrome, Fatty Liver and Hypertension

Metabolic syndrome combines a variety of medical disorders including obesity, type 1 diabetes, insulin resistance, and refractory hypertension, all of which increase the risk of developing cardiovascular disease. A research group led by Dr. Richard Johnson has identified the use of a specific variant of adenosine monophosphate deaminase 2 (AMPD2) as...

Published: 11/30/2023 | Inventor(s): Richard Johnson, Gabriela Garcia, Christopher Rivard, Miguel Lanaspa-Garcia

Disease Areas Endocrine/Metabolism, Endocrine/Metabolism, Endocrine/Metabolism, Endocrine/Metabolism, Hematology

Category(s): Therapeutics